High mobility group protein B1 (HMGB1) in asthma: Comparison of patients with chronic obstructive pulmonary disease and healthy controls

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 807-815

  Hou, Changchun ^a,b   Zhao, Haijin ^a   Liu, Laiyu ^a   Li, Wenjun ^a   Zhou, Xiaoting ^a   Lv, Yanhua ^a   Shen, Xiangbo ^a   Liang, Zhenyu ^a   Cai, Shaoxi ^a   Zou, Fei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; CORTICOSTEROID; HIGH MOBILITY GROUP B1 PROTEIN;

ADULT; AGE; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIC ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NONEOSINOPHILIC ASTHMA; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX; SMOKING; SPIROMETRY; SPUTUM LEVEL;

ADULT; AGED; ASTHMA; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HMGB1 PROTEIN; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; SPIROMETRY; SPUTUM;

EID: 79960726338     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00173     Document Type: Article

References (37)

1. Barnes PJ. (2008) Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8:183-92.
2. Saha S, Brightling CE. (2006) Eosinophilic airway inflammation in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 1:39-47.
3. Lotze MT, Tracey KJ. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 331-42.
4. Mitola S, et al. (2006) Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J. Immunol. 176:12-5.
5. Karlsson S, Pettila V, Tenhunen J, Laru-Sompa R, Hynninen M, Ruokonen E. (2008) HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care. Med. 34:1046-53.
6. Rowe SM, et al. (2008) Potential role of highmobility group box 1 in cystic fibrosis airway disease. Am. J. Respir. Crit. Care. Med. 178:822-31.
7. Taniguchi N, et al. (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48:971-81.
8. Ferhani N, et al. (2010) Expression of highmobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 181:917-27.
9. Straub C, et al. (2010) Elucidating the role of high mobility group box 1 (HMGB1) cytokine in a murine model of allergic asthma. J. Allergy Clin. Immunol. 125:AB108.
10. Bateman ED, Hurd SS, Barnes PJ. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 31:142-78.
11. Rabe KF, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care. Med. 176:532-55.
12. Miller MR, Hankinson J, Brusasco V. (2005) Standardisation of spirometry. Eur. Respir. J. 26:319-38.
13. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. (1997) Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur. Respir. J. 10:646-51.
14. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. (1959) The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br. Med. J. 2:257-66.
15. Robinson DS, Campbell D, Barnes PJ. (2001) Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised doubleblind placebo-controlled trial. Lancet. 357:2007-11.
16. Paggiaro PL, et al. (2002) Sputum induction. Eur. Respir. J. Suppl. 37:3s-8s.
17. Minas M, et al. (2010) Body composition in severe refractory asthma: comparison with COPD patients and healthy smokers. PLoS. One. 5:e13233.
18. Simpson JL, McElduff P, Gibson PG. (2010) Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration. 79:147-51.
19. Watanabe T, Asai K, Fujimoto H, Tanaka H, Kanazawa H, Hirata K. (2011) Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir. Med. 105:519-25.
20. Shang GH, et al. (2009) Serum high mobility group box protein 1 as a clinical marker for nonsmall cell lung cancer. Respir. Med. 103:1949-53.
21. Fabbri LM, et al. (2003) Differences in airway in-flammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 167:418-24.
22. Hou CC, Zhao HJ, Cai SX, Li WJ, Tong WC, Liu LY. (2010) Respiratory syncytial virus increases the expression and release of high mobility group box-1 protein in the lung tissue of mice. Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 30:700-3.
23. Hou CC, Zhao HJ, Cai SX, Liu LY, Shen XB, Mo GW. (2010) Expression of high mobility group box-1 in the lung tissue and BALF of asthmatic mice and the influence of dexamethasone. Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 30:2051-4.
24. Straub C, Pazdrak K, Stafford SJ. (2009) Involvement of high mobility group box 1 (HMGB1) in dendritic cell differentiation and activation of eosinophils. J. Allergy Clin. Immunol. 123:S252.
25. Quaedvlieg V, Henket M, Sele J, Louis R. (2006) Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics. Clin. Exp. Immunol. 143:161-6.
26. Straub C, Pazdrak K, Kurosky A. (2008) The novel inflammatory cytokine high mobility group box 1 protein (HMGB1) is actively released from human eosinophils upon stimulation with proinflammatory cytokines. J. Allergy Clin. Immunol. 121:S42.
27. Fahy JV, Wong H, Liu J, Boushey HA. (1995) Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am. J. Respir. Crit. Care. Med. 152:53-8.
28. Ito I, Fukazawa J, Yoshida M. (2007) Posttranslational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 282:16336-44.
29. Fu L, Cai SX, Zhao HJ, Li WJ, Tong WC. (2008) Effect of N-acetylcysteine on HMGB1 and RAGE expression in the lungs of asthmatic mice. Nan.Fang. Yi. Ke. Da. Xue. Xue. Bao. 28:692-5.
30. Fukami A, et al. (2009) Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population. Metabolism. 58:1688-93.
31. Saiwichai T, et al. (2010) Green tea extract supplement inhibition of HMGB1 release in rats exposed to cigarette smoke. Southeast Asian J. Trop. Med. Public Health. 41:250-8.
32. Hreggvidsdottir HS, et al. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86:655-62.
33. Willart MA, Hammad H. (2010) Alarming dendritic cells for allergic sensitization. Allergol. Int. 59:95-103.
34. Yanai H, et al. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 462:99-103.
35. Zhong N, et al. (2007) Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am. J. Respir. Crit. Care. Med. 176:753-60.
36. Zhao HJ, Lv YH, Liu LY, Cai SX, Shao JL. (2010) Analysis of the clinical indications of asthma control test. Nan.Fang. Yi. Ke. Da. Xue. Xue. Bao. 30:2084-6.
37. Saha S, et al. (2009) Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax. 64:671-6.